EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetics in autosomal dominant polycystic kidney disease

Zhipeng Yan, Feng Cao, Tingting Shao, Bingqing Liao, Guoping Wang, Xianhu Tang, Hongwen Luo, Fengjuan Zhu, Yunqiang Liao, Fengxia Zhang, Xiaosheng Li, Jian Wang und 2 weitere

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025

DOI: 10.1016/j.bbadis.2024.167652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Zhipeng Yan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Department of Nephrology, the First Affiliat…. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Epigenesis, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal dominant polycystic kidney disease (ADPKD) is the fourth leading cause of end-stage renal disease, contributing substantially to patient morbidity, mortality, and healthcare system strain. Emerging research highlights a pivotal role of epigenetics in ADPKD's pathophysiology, where mechanisms like DNA methylation, histone modifications, and non-coding RNA regulation significantly impact disease onset and progression. These epigenetic factors influence gene expression and regulate key processes involved in cyst formation and expansion, fibrosis, and inflammatory infiltration, thus accelerating ADPKD progression. Consequently, exploring epigenetic regulatory mechanisms presents a valuable pathway for developing novel therapeutic strategies and diagnostic biomarkers aimed at slowing or preventing ADPKD progression. This review systematically examines existing studies on epigenetic alterations-including DNA methylation, histone modification, and non-coding RNA regulation-in ADPKD patients, providing insights into gene expression changes and functions, and identifying potential drug targets for ADPKD treatment. CLINICAL SIGNIFICANCE: Autosomal dominant polycystic kidney disease (ADPKD) is the fourth leading cause of end-stage renal disease, causing significant morbidity, increasing patient mortality, and weakening the healthcare system. Further study on ADPKD has revealed that epigenetics plays an important role in the pathophysiological process of ADPKD. Epigenetics has a significant impact on the formation and progression of ADPKD through a variety of processes including DNA methylation, histone modification, and non-coding RNA. In addition to boosting cyst formation and proliferation, it induces cystic fibrosis and inflammatory cell infiltration, ultimately leading to a poor prognosis. This review summarizes the current understanding of the associated alterations in gene expression and function produced by epigenetic regulation in ADPKD, as well as potential treatment targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantEpigenesis, GeneticHumansDNA MethylationAnimalsHistone CodeRNA, UntranslatedHistonesDisease Progression

Stichwörter der Autor:innen

ADPKDDNA methylationEpigeneticHistone modificationNoncoding RNA regulation

Substanzen

RNA, UntranslatedHistones

Autor:innen und Institutionen

  • Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Department of Nephrology, the First Affiliated Hospital of Gannan Medical University, China.
  • Department of Nephrology, the First Affiliated Hospital of Gannan Medical University, China.
  • Department of Emergency, the Second Affiliated Hospital of Nanchang University, China.
  • Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, USA. El…

Zitieren

APA

Yan, Z., Cao, F., Shao, T., Liao, B., Wang, G., Tang, X., Luo, H., Zhu, F., Liao, Y., Zhang, F., Li, X., Wang, J., Liu, Z., & Zhuang, S. (2025). Epigenetics in autosomal dominant polycystic kidney disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167652

Vancouver

Yan Z, Cao F, Shao T, Liao B, Wang G, Tang X, et al. Epigenetics in autosomal dominant polycystic kidney disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2024.167652

BibTeX
@article{Yan2025,
  author = {Yan, Zhipeng and Cao, Feng and Shao, Tingting and Liao, Bingqing and Wang, Guoping and Tang, Xianhu and Luo, Hongwen and Zhu, Fengjuan and Liao, Yunqiang and Zhang, Fengxia and Li, Xiaosheng and Wang, Jian and Liu, Zhenzhen and Zhuang, Shougang},
  title = {Epigenetics in autosomal dominant polycystic kidney disease},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2025},
  doi = {10.1016/j.bbadis.2024.167652}
}
Kostenlos starten →